HIV/AIDS is your business - part one of an eight part series

Treating workers who have HIV/AIDS can save companies money by dramatically reducing productivity losses. But if companies get it wrong, they can increase the cost of HIV/AIDS to the company instead of reducing it.

SA is pilot site for HIV/AIDS Global Reporting Initiative

South Africa has been chosen as the pilot site for the testing of the first phase of the Global Reporting Initiative, and is expected to lead the way indeveloping a set of internationally recognised HIV/AIDS reporting standards for business.

It is economically viable to treat your workers - part 2 in series

In most South African companies it is cheaper to treat than to ignore HIV/AIDS in the workforce. Analysis of 70 South African companies by FutureForesight, the firm of HIV workplace economics specialists, has shown the viability of completely funding HIV treatment in most cases.

Cotlands / Chris Hani Baragwanath HIV/AIDS counselling initiative

The Cotlands/Chris Hani Baragwanath HIV/AIDS Counselling Project, sponsored by the Nedcor Foundation, is believed to be the first of its kind worldwide, and is expected to become a showcase to the rest of the world by providing a successful model of counselling services to HIV-positive children and their parents/primary care givers - and especially to those who have children in the last stages of the disease.

HIV treatment cheaper than none, business told

Zackie Achmat says that for about a month each year, he and his body work at between 20 and 40% of full capacity.

Time for savvy managers to shoulder intervention schemes - part three

Many companies are destroying shareholder value by implementing partial HIV/AIDS programmes. Employers are either holding off on treatment or implementing minimalist interventions, in the mistaken belief that they are saving money.

Factory sets up fund for HIV-infected employees

A palm oil factory in the Central African Republic (CAR) has vowed to set up a special fund, to which all employees will contribute 1 percent of their salaries, to buy drugs for HIV/AIDS-infected employees.

The more you treat, the more money you save - part four of eight

Company executives should be good at strategy, but the way most firms manage HIV/AIDS in the workforce shows there are some things they don't understand. They allow profiteering schemes to undermine HIV/AIDS treatment.

Doing too little, too late is money wasted - part five of eight

In part two of this series, we spoke about the economic viability of treating the workforce. International and local studies have shown that treating the workforce would save the company money. Simply put, antiretroviral treatment costs less than the absenteeism, loss of productivity and disability costs that are incurred as an employee becomes ill when treatment for HIV/AIDS is not available.

Micro Enterprise Alliance launches HIV/AIDS tool kit

The Micro Enterprise Alliance has launched an HIV/AIDS workplace programme for small enterprises.